The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. But one that has flown under the radar,
Atomic AI combines artificial intelligence analysis with wet lab experiments to discover small molecules capable of drugging RNA. The startup, based on technology initially developed at Stanford, is backed by a $35 million Series A round of financing.
A Vision of Metascience scienceplusplus.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceplusplus.org Daily Mail and Mail on Sunday newspapers.